ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Neovacs Sa

Neovacs Sa (0W8U)

29,040,000.00
0.00
(0.00%)
Closed January 05 11:30AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
29,040,000.00
Bid
0.00
Ask
0.00
Volume
0.00
0.00 Day's Range 0.00
29,040,000.00 52 Week Range 29,040,000.00
Market Cap
Previous Close
29,040,000.00
Open
-
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1,754
Shares Outstanding
3,516,842,000
Dividend Yield
-
PE Ratio
-11,616,000,000.00
Earnings Per Share (EPS)
-0
Revenue
534k
Net Profit
-8.74M

About Neovacs Sa

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Suresnes, Hauts-de-seine, Fra
Founded
-
Neovacs Sa is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker 0W8U. The last closing price for Neovacs was 29,040,000.00 €. Over the last year, Neovacs shares have traded in a share price range of 29,040,000.00 € to 29,040,000.00 €.

Neovacs currently has 3,516,842,000 shares outstanding. The market capitalization of Neovacs is 102,129.09 € trillion. Neovacs has a price to earnings ratio (PE ratio) of -11616000000.00.

0W8U Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10029040000290400002904000000DE
40029040000290400002904000000DE
1200290400002904000029040000175429040000DE
2600290400002904000029040000107729040000DE
520029040000290400002904000055329040000DE
15628998760.188270317.392215741239.81176562904000041239.81176561704023267536.6306DE
26028998760.188270317.392215741239.81176562904000041239.8117656658483646485.95669DE

0W8U - Frequently Asked Questions (FAQ)

What is the current Neovacs share price?
The current share price of Neovacs is 29,040,000.00 €
How many Neovacs shares are in issue?
Neovacs has 3,516,842,000 shares in issue
What is the market cap of Neovacs?
The market capitalisation of Neovacs is EUR 102,129.09T
What is the 1 year trading range for Neovacs share price?
Neovacs has traded in the range of 29,040,000.00 € to 29,040,000.00 € during the past year
What is the PE ratio of Neovacs?
The price to earnings ratio of Neovacs is -11.62B
What is the cash to sales ratio of Neovacs?
The cash to sales ratio of Neovacs is 145.2B
What is the reporting currency for Neovacs?
Neovacs reports financial results in EUR
What is the latest annual turnover for Neovacs?
The latest annual turnover of Neovacs is EUR 534k
What is the latest annual profit for Neovacs?
The latest annual profit of Neovacs is EUR -8.74M
What is the registered address of Neovacs?
The registered address for Neovacs is 14, RUE DE LA REPUBLIQUE, SURESNES, HAUTS-DE-SEINE, 92150
What is the Neovacs website address?
The website address for Neovacs is www.neovacs.com
Which industry sector does Neovacs operate in?
Neovacs operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discussion

View Full Feed
Mr. Bill Mr. Bill 7 minutes ago
https://www.medicinenet.com/what_are_blood_oxygen_levels/article.htm
devil dog 96 devil dog 96 8 minutes ago
Tell everyone why you think they never took the 39 million shares off restriction if they need shares to dump? Why have they not taken 1 share off restriction since early 2021 if they need shares to dump?? Why would they issue new shares that will be unregistered and also have to wait a year before
ATMH
CrossFireTrader CrossFireTrader 8 minutes ago
Page 22 of 26, and If say I'm Bullish that'll set 280e off, and I'll  be accused of pumping our little lottery ticket. I'm here for the long haul. I'm not here to sell at 0.016 or 0.02 or 0.03 or whatever his new price is. He actually likes GDVM a lot more than he lets on. Since you seem to be somew
GDVM
Mr. Bill Mr. Bill 12 minutes ago
https://measuringmyhealth.com/what-is-a-normal-pi-on-a-pulse-oximeter/
georgejjl georgejjl 12 minutes ago
That is WRONG. The current standard of care is donepezil (Aricept) and memantine, etc.

MAB's still are an extremely small number of treatments for Alzheimer's in the USA and worldwide.

Good luck and GOD bless,
AVXL
axelvento axelvento 32 minutes ago
Q1 the first interim analysis of the vaccine’s efficacy is expected

Moderna’s mRNA-1647
Cytomegalovirus
MRNA
MightyX MightyX 35 minutes ago
Yet no one is innocent
TPTW
BIG D 4 BIG D 4 36 minutes ago
WOW !! HAPPY NEW YEAR TO ALL THE LONGS HERE !! I HAVE 2 NAYSAYERS ON IGNORE SO I NEVER READ THEIR BS !! GO SAVING GRACE-- JJ AND ALL THE NEW POSTERS WHO ARE POSITIVE !! .02 CENTS TO START THE RUN TO ONE DOLLAR IS WHERE WE SHOULD BE !! THIS STOCK IS SUCH A GREAT BUY HERE !! I AM LOADED WITH 32 MILLI
MJNA
MightyX MightyX 36 minutes ago
The judicial system legitimizes prosecution
TPTW
jondoeuk jondoeuk 37 minutes ago
A new paper. From it: 'BNT221 was well tolerated across both DLs, with no dose-limiting toxicities of grade 3 or higher attributed to the T cell product observed. Specifically, no cytokine release, immune effector cell-associated neurotoxicity or macrophage activation syndromes were reported. A dose
BNTX
benz280c benz280c 38 minutes ago
Nice to see you are bullish. This quote may round out your knowledge.
"It is worthy to note that a new CUSIP has been approved by the CUSIP Global Services (CGS).
Subsequently, we have submitted a corporation action with FINRA for a Company name change, Ticker Symbol Change and Cusip
GDVM
shajandr shajandr 39 minutes ago
Sorry to read that you're still feeling sick. I posted a week or two ago about 41 bunnies and also some cats and dogs that were rescued from a home in Delaware county, Iowa and that were transferred to the DBQ county animal shelter. I just spoke with DaSqu_w and she went to the animal shelter to see
Lakota-45 Lakota-45 40 minutes ago
Will do, but I doubt they will listen !!!

~ Lol !!!
IONI
boi568 boi568 41 minutes ago
Probably
AVXL
HokieHead HokieHead 43 minutes ago
Wrong..
TWOH
HokieHead HokieHead 44 minutes ago
Get your facts straight, the halt was in the Canadian side as they are reviewing all the disclosures submitted, there’s ZERO issues in the US, it’s a fully reporting SEC company.
TWOH
Lakota-45 Lakota-45 45 minutes ago
I agree with you 'farmI1234 !!!

I'm pretty sure most of the Savvy Investors, that have been paying attention,
have been loading the dips, and .0004's, for a while now.
I know I have, along with fishing down stream.

I doubt any Longs will get caught short,
WDLF
CaptHowdy CaptHowdy 47 minutes ago
RECOMMENDED.... nothing is offical yet, unnecessary twisting of facts to bolster your negative viewpoints. Thats news is two months old
GRLT
axelvento axelvento 47 minutes ago
Cancer vaccines: What’s ahead in 2025

The spotlight is on mRNA-4157 (V940)

https://gulfnews.com/special-reports/cancer-vaccines-whats-ahead-in-2025-1.500010233
MRNA
facts_matter14 facts_matter14 48 minutes ago
Does this sound like a company with 16 products and a 17th on the way?

https://investorshub.advfn.com/uimage/uploads/2024/12/24/mwowsIMG_6034.png








.
SRMX
HomerRomer HomerRomer 48 minutes ago
More testimony videos from trial participants like the Australian news reel of Ern Heaven would be amazing. I would think that most of the people involved 9 years ago in the earlier phase studies have passed on since the average life expectancy is normally between 3-11 years after being diagnosed w
AVXL
CaptHowdy CaptHowdy 49 minutes ago
That's how to make money on the OTC. 🤦🏻‍♂️ Anyone could do it; only if the effort spent discounting the new leadership in place along with the turn around story underway was used to turn a profit vs. using 9yr old DD to bad mouth new CEO.
GRLT
crescentmotor crescentmotor 50 minutes ago
I think that is a bad precedent to start.

100% on parading a handful of Blarcamesine patients at the JPM conference. I highly doubt AVXL would involve itself with anecdotal gimmicks where there is no way possible to extrapolate isolated successes to meaningful conclusions about broad
AVXL JPM

Your Recent History

Delayed Upgrade Clock